StockData
Accendra Health Inc logo

Accendra Health Inc (ACCH) revenue by segment

ACCHWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31Also trades as ACH
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3098% below fair value
Share price
Not available yet

Price, market cap and P/E appear here once daily prices are connected.

Accendra Health Inc revenue by segment

By business segment

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016% of revenueYoY
Patient Direct–$2.68B$2.55B$2.06B$959.67M$817.75M––––––
Products & Healthcare Services–$8.02B$7.78B$7.90B$8.83B$7.66B––––––
Global Products––––$2.66B$1.81B$1.43B$1.11B$504.03M$539.58M––
Global Solutions––––$7.86B$7.21B$8.24B$8.77B$9.19B$9.54B––
Proprietary Products––––––––$504.03M$539.58M––
Operating incomeFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016YoY
Patient Direct–$260.16M$246.86M$193.75M$57.97M$67.66M–––––
Products & Healthcare Services–$53.01M$57.81M$175.31M$384.39M$215.70M–––––
Global Products––––$371.93M$259.93M$65.05M$75.69M$38.46M$59.38M–
Global Solutions––––$66.63M$30.95M$83.59M$108.76M$141.09M$175.51M–
Proprietary Products––––––––$32.95M$53.80M–

By product or service

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016% of revenueYoY
Diabetes$783.37M$777.48M$723.32M–––––––28.4%+0.8%
Sleep therapy$740.05M$702.95M$669.78M–––––––26.8%+5.3%
Home respiratory therapy$433.05M$435.95M$457.68M–––––––15.7%-0.7%
Other$288.19M$268.27M$254.97M–––––––10.4%+7.4%
Ostomy$212.84M$195.92M$177.89M–––––––7.7%+8.6%
Wound care$188.51M$192.41M$170.95M–––––––6.8%-2.0%
Urology$116.02M$107.12M$97.99M–––––––4.2%+8.3%

By region

RevenueFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016% of revenueYoY
United States–$10.46B$10.06B$9.53B$9.25B$8.13B$8.87B$9.26B$8.90B$9.34B––
International–$242.94M$275.29M$429.44M$534.98M$349.77M$339.34M$157.04M$419.07M$384.89M––
France––––––––$39.28M$38.76M––
Germany––––––––$49.23M$47.51M––
United Kingdom––––––––$175.70M$169.87M––
Other European countries––––––––$97.92M$87.53M––
Ireland––––––––$56.94M$41.21M––

From the segment and revenue-disaggregation notes of Accendra Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes. The KPIs tab shows these segments next to Accendra Health's operating metrics, with full history, charts and a link to each filing.

Operating metrics

Countries of operationFY2024FY2023FY2022FY2021YoY
Countries of operation808070700.0%

Counts and sizes Accendra Health tags in the notes of its 10-K and 10-Q filings (XBRL), as of the end of each period. Breakdowns follow the company's own labels; at most 15 are shown per metric.

See a number that looks wrong?